Question 1

How does the IQVIA Vigilance Platform improve pharmacovigilance efficiency and compliance in life sciences organizations?

Accepted Answer

The IQVIA Vigilance Platform is a true SaaS solution that simplifies and automates pharmacovigilance processes end-to-end, from adverse event intake through case processing to regulatory submission. By leveraging AI, machine learning, and automation, it reduces manual tasks, enhances data accuracy, and accelerates reporting timelines. This results in significant cost savings, compliance with evolving global regulations, and faster identification and management of drug safety risks.

Question 2

What are the key technological features of the IQVIA Vigilance Platform that support modern drug safety operations?

Accepted Answer

The platform integrates safety-specific AI and machine learning models, innovative automation tools, and multilingual, user-friendly interfaces. It offers real-time analytics, comprehensive data security with role-based access controls, and seamless integration with existing IT environments. Features such as multi-channel adverse event intake, configurable workflows, and automated periodic reporting allow organisations to scale safety operations efficiently while maintaining high-quality oversight.

Question 3

How does IQVIA Vigilance Platform support proactive risk management and data-driven decision-making in pharmacovigilance?

Accepted Answer

QVIA Vigilance Platform delivers near real-time data and advanced signal detection capabilities to surface emerging safety concerns quicker than traditional methods. Its robust analytics and dashboard tools enable cross-functional teams to drill down into case data, monitor compliance metrics, and perform comprehensive risk-benefit assessments. This transparency and rapid insight empower life sciences companies to make timely, evidence-based decisions that enhance patient safety and regulatory compliance.

Useful Links

Our Services

Contact Us